Diagnostic significance of cerebrospinal fluid EGFR mutation analysis for leptomeningeal metastasis in non-small-cell lung cancer patients harboring an active EGFR mutation following gefitinib therapy failure-Reference-Cited by-同舟云学术

Diagnostic significance of cerebrospinal fluid EGFR mutation analysis for leptomeningeal metastasis in non-small-cell lung cancer patients harboring an active EGFR mutation following gefitinib therapy failure

Published:2016-01 Issue:1 Volume:54 Page:14-19
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Sasaki Shinichi,Yoshioka Yasuko,Ko Ryo,Katsura Yoko,Namba Yukiko,Shukuya Takehito,Kido Kenji,Iwakami Shinichiro,Tominaga Shigeru,Takahashi Kazuhisa

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference30 articles.

1. Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS);Fukuoka;J Clin Oncol,2011

2. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib;Omuro;Cancer,2005

3. Leptomeningeal metastases from solid malignancy: a review;Taillibert;J Neurooncol,2005

4. The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors;Soffietti;Semin Oncol,2009

5. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment;Chamberlain;Semin Oncol,2009

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Riddle of the Sphinx: Progress in Leptomeningeal Metastasis of Non–Small Cell Lung Cancer;Clinical Medicine Insights: Oncology;2023-01

2. CSF and disease;Cerebrospinal Fluid and Subarachnoid Space;2023

3. The Mechanism of Nemo-Like Kinase (NLK) in Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating Vascular Endothelial Growth Factor (VEGF);Journal of Biomaterials and Tissue Engineering;2022-12-01

4. CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma;Cancer Medicine;2022-09-09

5. High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience;JTO Clinical and Research Reports;2022-06